Jian-Xin Zhou
9
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Use of Endotracheal Tube Cuff Pressure to Assess Inspiratory Effort During Pressure Support Ventilation
Role: lead
Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways
Role: lead
Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
Role: lead
Comparison of Physiological Effects of Two High-Flow Tracheal Oxygen Versus T-Piece During Spontaneous Breathing Trials
Role: lead
Comparison of Physiological Effects of Two Types of High-Flow Oxygen Therapy in Tracheostomized Patients
Role: lead
The Clinical Feasibility and Validity of PMIvent to Access Inspiratory Effort During Pressure Support Ventilation
Role: lead
Inspiratory Contribution of Pressure Support-ventilated Patients in Different PMI Conditions
Role: lead
Economic Impact of mNGS on Diagnosis of Post-neurosurgical Central Nervous System Infection
Role: lead
Patient-ventilator Asynchrony in Patients With Brain Injury
Role: lead
All 9 trials loaded